Skip to main content
logo
Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
1.800
+0.020 (1.12%)
At close: Jul 30, 2026, 4:00 PM EDT
1.780
-0.020 (-1.11%)
After-hours: Jul 30, 2026, 8:00 PM EDT

Regentis Biomaterials Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-13.654.8-4.13-1.45-5.14
Stock-Based Compensation
7.04----
Other Adjustments
5.1-3.842.20.074.42
Changes in Accounts Payable
0.01-0.10.15-0.1-0.03
Changes in Accrued Expenses
0.28-1.260.10.091.24
Changes in Other Operating Activities
-0.16-0.240.46-0.11-0.36
Operating Cash Flow
-1.38-0.64-1.22-1.50.13
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
0.30.40.33--
Short-Term Debt Repaid
--0.33---
Net Short-Term Debt Issued (Repaid)
0.30.080.33--
Long-Term Debt Issued
-0.45--1.24
Net Long-Term Debt Issued (Repaid)
-0.45--1.24
Issuance of Common Stock
8.22----
Net Common Stock Issued (Repurchased)
8.22----
Financing Cash Flow
8.520.530.33-1.24

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
7.15-0.12-0.9-1.51.37

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1.38-0.64-1.22-1.50.13
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-2.43-1.13-7.03-9.270.80
Levered Free Cash Flow
-13.223.73-3.1-1.577.23
Unlevered Free Cash Flow
-6.84-0.67-1.22-1.531.52
SEC Filings: 10-K · 10-Q